Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale

NCT06012266 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Dapagliflozin tablet
DRUG: Empagliflozin Tablets

Sponsor

Centre Hospitalier Universitaire Vaudois

Collaborators

[object Object]
[object Object]